throbber
SEVENTH EDETION
`
`AND DRUG
`
`DELIVERY SYSTEMS
`
`PHARMACEUTICAL
`DOSAGE FORMS
`
`
`
`Howard C. Ansel
`
`Loyd V. Allen, Jr.
`
`Nicholas G. Popovich
`
`AstraZeneca Exhibit 2106 p. 1
`InnoPharma Licensing LLC v. AstraZeneca AB IPR2017-00904
`Fresenius-Kabi USA LLC v. AstraZeneca AB IPR2017-01910
`
`

`

`Editor: Donna Balado
`Managing Editor: jennifer Schmidt
`Marketing Manager: Christine Kushner
`
`Copyright © 1999 Lippincott Williams & Wilkins
`
`351 West Camden Street
`Baltimore, Maryland 21201—2436 USA
`
`227 East Washington Square
`Philadelphia, PA 19106
`
`All rights reserved. This book is protected by copyright. No part of this book may be re-
`produced in any form or by any means, including photocopying, or utilized by any infor—
`mation storage and retrieval system'without written permission from the copyright owner.
`
`The publisher is not responsible (as a matter of product liability, negligence, or otherwise)
`for any injury resulting from any material contained herein. This publication contains in—
`formation relating to general principles of medical care which should not be construed as
`specific instructions for individual patients. Manufacturers’product information and pack—
`age inserts should be reviewed for current information, including contraindications,
`dosages, and precautions.
`
`Printed in the United States ofAmerica
`
`Library of Congress Cataloging-in-Publication Data
`
`Ansel, Howard C., 1933—
`Pharmaceutical dosage forms and drug delievery systems / Howard C,
`Ansel, Lode. Allen, Ir., Nicholas G. Popovich. —— 7th ed.
`p.
`cm.
`Includes bibliographical references and index.
`ISBN 0—683—30572—7
`2. Drug delivery systems.
`1. Drugs—Dosage forms.
`11. Popovich, Nicholas G.
`Ill. Title.
`[DNLM: 1. Dosage Forms.
`2. Drug Delivery Systems. QV 785 A618i 1999]
`RS200.A57
`1999
`615’.1—dc21
`DNLM/DLC
`for Library of Congress
`
`1. Allen, Lode.
`
`99—17498
`CIP
`
`The publishers have made every effort to trace the copyright holders for borrowed material. Ifthey
`have inadvertently overlooked any, they will be pleased to make the necessary arrangements at
`the first opportunity.
`-
`
`The use of portions of the text of USP23/NF18, copyright 1994, is by permission of the USP
`Convention, Inc.The Convention is not responsible for any inaccuracy of quotation or for
`any false or misleading implication that may arise from separation of excerpts from the
`original context or by obsolescence resulting from publication of a supplement.
`
`To purchase additional copies of this book call our customer service department at (800)
`638—3030 or fax orders to (301) 824—7390. International customers should call (301)
`714—2324.
`
`99 00 01 02
`1 2 3 4 5 6 7 8 9 10
`
`AstraZeneca Exhibit 2106 p. 2
`
`

`

`
`
`Contents
`
`Preface
`
`Acknowledgments
`
`Section I. PRINCIPLES OF DOSAGE FORM DESIGN AND DEVELOPMENT
`
`I
`
`2
`
`3
`
`4
`
`5
`
`Introduction to Drugs and Pharmacy
`
`New Drug Development and Approval Process
`
`Dosage Form Design: Pharmaceutic and
`Formulation Considerations
`.
`
`Dosage Form Design: Biopharrnaceutic and
`Pharmacokinetic Considerations
`
`Current Good Manufacturing Practices and Good
`Compounding Practices
`
`Section II. SOLID DOSAGE FORMS AND MODIFIED-RELEASE DRUG DELIVERY SYSTEMS
`
`6
`
`7
`
`8
`
`Powders and Granules
`
`Capsules and Tablets
`
`‘
`
`Modified~Release Dosage Forms and Drug Delivery Systems
`
`Section III. SEMI-SOLID AND TRANSDERMAL SYSTEMS
`
`9
`
`TO
`
`Ointments, Creams, and Gels
`
`Transdermal Drug Delivery Systems
`
`v
`
`vii
`
`1
`
`23
`
`60
`
`101
`
`142
`
`164
`
`179
`
`229
`
`_
`
`'244
`
`263
`
`ix'
`
`AstraZeneca Exhibit 2106 p. 3
`
`

`

`x
`
`Contents
`
`Section IV. PHARMAEEUTICAL INSERTS
`
`IT
`
`Suppositories and Inserts
`
`Section V. LIQUID DOSAGE FORMS
`
`I 2
`
`T3
`
`S olutions
`
`Disperse Systems
`
`Section VI. STERILE DOSAGE FORMS AND DELIVERY SYSTEMS
`
`T 4
`
`I 5
`
`lb
`
`Parenterals
`
`Biologicals
`
`Ophthalmic Solutions and Suspensions
`
`Section VII. NOVEL AND ADVAN(ED DOSAGE FORMS, DELIVERY SYSTEMS, AND DEVIEES
`
`Radiopharmaceuticals
`
`Products of Biotechnology
`
`Novel Dosage Forms and Drug Delivery Technologies
`
`Systems and Techniques of Pharmaceutical Measurement
`
`T 7
`
`18
`
`T9
`
`Appendix
`
`Index
`
`279
`
`296
`
`346
`
`397
`
`450
`
`469
`
`487
`
`503
`
`535
`
`552
`
`563
`
`AstraZeneca Exhibit 2106 p. 4
`
`

`

`Seaman VI. SterflE Image Rams and Delivery Systems
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PARENTERALS
`
`
`
`Chapter at a Glance
`
`hijacfians
`Parmieml Rmzéea afAdmiflisfi'atésm
`Inwavamua Rama
`Intramuscular Ruute
`Subcutanaoua Rama
`Intraderm :31 Route
`
`Specialized access
`Gficial Types 0f Injefltiana
`Salvems aim? Vehicleg far Iajesfisnfs
`Namqueeus Whisks
`Acidegi Szebsfimzcas
`
`Meihads cngtarilz’zafiimz
`Sfaam Sterilizatian
`
`wafieat Sterilizatinn
`Steriligafitm 1'33: Filt‘ratican
`Gas Stariiizatim
`
`Starilizaficm by Ianizixxg Radiatim
`Vaiféaifm? af Steriiity
`Fyrogena and Pwagen Testing
`The Industriaf Preparatian Bf Paramemz‘
`Pretfucts
`
`Lispm Inszdin Safiufim
`Impfizsma Insulin 3333333185331
`{MPH Insulin)
`{swims Insulin Suspezzsfau :sz
`Insulin: Injecffan
`Insmfifl Zinc Su’speuaimz
`Exféndeai Insulin Zia: Suspenss‘w
`I’mmpt Insult??? Zinc: Szgapemfm
`frgsufiin Imfitsian Pumps
`Large Vulume Parmierals (LVPE)
`Maimwwce Thérapy
`1233;313:362}:th Therapy
`Wafer Requfimmf
`Elecirslyée Requirement
`Calisric Reguiramerzis
`Parenteral Hyperalimenmtfan
`€211:ng Nutrffim
`
`Paskagifig; {(623581ng am? Signage 9f Injgcw
`{fans
`
`szlffy Assurancefm‘ Phammcgfifiepm'ed
`Sfm‘le Pradmts
`
`Availabfe Injgcfifmzs
`Small Volume Famnterals
`IflSulm Injeciian (Regular)
`Human Msuiifi
`
`Infimvemus {fifugim Gamma
`Special consideratians assaciafied with
`parexwteral therapy
`Agisarpiian (3f Ergggs
`Hanéziflgxflfspwal 0f Chematfzémpemfc:
`Agmisfor (3:23:55?
`Qiher hxjectabie Pmduatsmli’eflets m:
`Implants
`Lemmrggatrel fmpfsmts
`Irrigatiam anti Diaiysis Saluéiens
`Imgntima Safutimzs
`Bmfysis Safizgtémw
`
`CONSIDERED EN this chapter are mpmtam pharma-
`centical {insage farms that have the mmmon char
`aateristic: (13f being prepamd ta be sterile; that is, free
`fmm cantaminating micrmrganismafimang these
`sterile damage farms are the varimus small« and
`Eargevmiume immutable preparaflans, irrigatim find!
`
`ids intended ta bathe heady wmmis 0r surgical
`cpmings, anti dialysis saiufimns. Bialegica} prepa-
`ratimg 35 memes: tamidag and amimxins are aim
`
`ammg this gmup and discusseci in Chapter 15*
`Steriiity in these preparatiens is sf utmmst impar-
`tanm because they are piaced in {meat mutant: Mich
`397
`
`Astraleneca Exhibit 2106 p. 5
`
`

`

`398
`
`Parenterels
`
`the inteme¥ baud}? fluids er tissues where infeetien
`can easily arise: Qphthaimie preparatiene, which
`axe aim preeared to be sterile; wili be discueseel
`eeperateiy in Chapter 15.
`
`Inj ectiens
`
`Injectiems ere Sterile, py‘regen-~free preparatians
`intended tea be adminietereti parenteraily. The
`term pareszterei refeee t0 the injeetabie reuiee 0f
`eciminietretien. The teem has its derivetien free:
`
`the Greek wards gram and entemn, meaning
`eutsicie ef the intestines and deueiee reutee £35 each
`
`mieietretien ether than the era! mute. Eyregens
`are feverwpwdueing ergeme embetaneee arising
`fmm miembiei centeminefiae and are respons-
`ible fez: many ef the fe‘eeile reeetiens which DCCLII‘
`En patiente feliewing intraveneus injeetmn. Pyrw
`gene and the determinatien exit" their eresenee in
`parenteral} preparatiens will be {iiseuseed later
`in this chaptee In generei. the earenteral mates
`ef administreeien are mxdetteken when rapid
`drug aei'ier: ie ciesiz‘ed‘ as in emergency situeiiens,‘
`when the patient is unmnpemtiva, unemuficimze:
`Qt unable to aecept m“ reiterate mecficatim by
`the era]. mute, {15' when the shrug itself is ineffective
`by ether meme. Wiih ”the exeeptien {3f 1:15:11 in in“
`jectiens: which are cemmwlj; sefiasimmistered
`by diabetic patients, meet injeeiiens are adminis-
`tered by the physician hisfhet assistant, {31* nurse
`in the meme Gf' medieai treatment, Thus injeee
`titans are empieyeci meetiy in the Meme}, ex«
`tended care fecfiity, and efinie and £333 frequenfly
`in the heme An exceptien waged be in heme health
`care pregame in which health professieneis
`pay scheciuked Weite re patients; in their hemes,
`prewdifig needed teeetmem including mire»
`venaue medicaiiem. These pregame enable paw
`Heme thi} {m 11m require or are unable in page Em
`mere expensive haspitaiizatim m remain in the
`famiiiar surmumiings cf their immes while renew
`ing appmpriate meeiieal care. The pharmacist
`supplies: injectabie preparatimns m the physician
`and nmseg es :eqmired fer thee use in fine mew
`time} setting, {152111; mffice; er heme Inez-31th care
`program.
`Perhaps the earliest injectehle dmg m reeeive ofr
`fieial remgnitian was the hypadermie meerphme
`soiu‘cian‘. which appeared first in the 183% addew
`dum m the 1853’? “Britieh Pharmacopeiaj am? later, in
`1888 in the fire? edifim of the Natianai Fem“: 11131}:
`{if the United States, Tadey, there are literally hmn,«
`dreds of drugs ami drug prmducm awaiieble Em pap
`emerai admfimmafrien.
`
`Parenteral Rautes afAdministrefian
`
`1311th may be injected We eimesi‘ any ergan es:
`area ef the besiy, including the jeims {faire‘eréim~
`Im’}, a jeintifiuid area {femsyneefelg the spmel mi»
`umn {feimspéeel}, ieta epinel fluid (fetmrizeeefx ee-
`teeies {Enfs'aaez'fer‘fe‘f}, am in em emergency even
`mm the heart {Eefireeeréiee}. Heweeexg meet cam»
`maniy ingestiees are perfermed inter: e vein {mere—
`meme IV), irate a muscle {fetmreuseele‘e 1M): mm
`the skin (Regimental, £22. inhemmeeem or meet
`the skin {eeeemeeeaee Si; 5&2an SQ, eypeeemzie,
`Ewe} {Fig 14.1}.
`
`Intraveneus Rflute
`
`The intraveneus injeetien ef {hugs had its scieni
`tiff: eeigin in 1536 in the eepefimeme eff Sir Christe»
`phat Wren, architect a? St. Paul’s Cathedral and
`amateur yhysielegiet‘ Using a hiecider and quill fer
`a syringe and needle: he injected wine, aie, Qpiumg
`and ether substantes inta the veins cf siege and
`studied their effeete, Intreveneue medieefien was
`
`firet gieee m humans by Iehenn Same} Meier of Kiel
`in 3,651 bu: was abandnned far a paged became m?
`the accurrence cf thwmbesis anti embolism in the
`
`patients 3e treeted.’fhei1wentien a? the hypedermie
`
`swinge tweed the middle of the 19th century new
`ext-ed a new interest in intraveneus techniques and
`beware the mm «3% {he cement} intreeefleue admin-
`ietretien ef aeiutieee GE sedium efleride anti glueese
`became peyuia nTedayg the intraveeeus edministre»
`rim :3? cimge is. a mufine eecurreuee in the heeeiteh
`altimetgh there are stili reeegnieeafi cimxgers esseeie
`ateci mm we practice. Thrembus em} emhehzs fen
`matiem may be induced by ineeeeneue medias; and
`are:rheteme end the peseibility ef perticuiare matter in
`parenteral eelutimns peaee ceneem for these in~
`valved in the deveiepment, adminietretiem ami use
`an? intravenme mintiem.
`
`Infieeeneuely ackrfiflistered drugs {swede rapid
`acticm compared with ether mates ef administra-~
`tier: and beeamee drug absmpfiee is net a facts;
`mptimum bioed levels may be achieveci with the ac~
`mracg and immediacy net pessible by ether mate’s.
`In emergency simatiens,‘ the intraveneue adminie
`{ream 0f admg may be e lifesaving procedure flee
`tame of the placement 0f the drug directiy irate the
`circulatimn anti the prempt action weigh enemas;
`On the negative side! fiance a drug is; adminiatered
`intravenousix it cannot be reviewed In the case :21?
`an adverse :eactiem tn the mug, fer iflStEI‘ECE‘, the
`drug mnmt be easily rammed fmm the circuiatim
`as it mum, Em example. by the inducfien 0f Emmi?-
`mg after the ma} afiminietmtian {1f the same (frag.
`
`Astraleneca Exhibit 2106 13* 6
`
`

`

`Pamitemls
`
`399
`
`Subcuzanemux
`
`
`
`lmtadermai
`(«a
`
`62$
`' k
`«wk
`
`
`
`
`Subcutauwus
`Tiiwa
`
`Shhmm-memm
`xii-(Signs?
`Tiswe
`
`Mums: and Win
`
`
`
`£01;th Efpstramgmf fidmzziistmtz‘m Numbm at: medias :Jzéicszfg fiézeargauga ckf mafis mm {:12 amsidg dzawstar a}:
`Fig. 1&1
`Hawk sfiafi {Rat-farm we”123:1 Femigsigm fram Threw S; Kiflg RE. Smrfie 3mg: Farm: Thai: Prgpgmfism :3:sz (Ilium? Ayyéém-
`Hams» 3rd Ed. Lat: 53* Fetzigey; WSW
`
`Mrhaugh was: superficial veins are guitable f9:
`wnipumtum the: veins cyf the antesmbitai area {sit'
`uatezi in Emmi: GE the elbuw} are 213MB}! selactacl far
`direct intravenous iajectiwffhe wing in this {Caca*
`titan are large, superficial, afid eag}! 1:0 SEE and enter.
`Must clinicians insert the net‘die with the have} fa?
`
`mg upward, at the must acute angie pcsaihie with
`the vein; m {Ensure that ihe diz‘aaticm :35 flaw :3? the
`inflatable is that inf the flaw {2’5 the 13mm. Sim?
`aseptic grecauticms must be taken at all fix-neg {a
`await? risk af infectian. Nat only ate the injentabie
`seiutians stature,“ fhe gyringes and neefiieg used
`must alga be sterilized and the paint <33? entrance
`must be diainfecteti m reduce the chance 0f carry-
`ing bacteria from the fikin mm the bkmd via the
`needle 1%me injeqtinm afiministgafimx parsmne‘i
`mum mmdmw the 13111:“:gar {if the syringe 0r squefiza
`a special bulb §ound an mast IV 3am in ensure that
`the media has been properly heated. in bath inw
`mamas; a“flashba€k”af mead mm the adminigira—
`
`time set at the syfinge indicates pIQpEE placement
`of the needle within the vein.
`
`[mm 51711312 and fiery: mlumesz a? drug aoiutions
`may be adminis’camd infiavemusiy Tim use @f
`188(3me cantainers of smiutims fflf intravenous
`
`infusi-im is mmmmgiace is“: the haspitaifflwae we
`Iufims mmiaifiing such agents as nutziantg, blami
`axtfinéemé gleetmlytes: amim} acids: am? ether {hay
`apeutir: agents are administered thraugh an in—
`dweiiing aaadlfi m camera: by ccnfinumm infusém.
`Th6: infusifln Ctr flaw rates may be afijusmd by the
`ciiniciafi awarding ta the needs af the patiem.
`{Emerallfi {Ems ratea £13: intravamus fluids aw ax»
`grasseci in mLihmm am} mags: Fran”: £12 tn 1523
`mtham Lawgr rates are useé Ear“keep apart”
`lines. Fm iiitravenmzs infijsian, the aka-mile m: Caitheter
`
`is glacaci in am pramimant veins af the farearm {33'
`kg and "zapsd firmly tax the: patient saw that it m1} nm
`slip 5mm place dufimg infusimfha main hamrci at?
`intravenms infm‘simx E3 the paasibility :31" thwmbxis‘.
`£63113th induced by the teuching 9f the wali 43f
`the vein by this catheter at media. Thmmhi are
`mam Eikei}; {a 13mm? when the infusion Wham i5;
`mi an £31:ng nature t0 the bimlagic tissues. A
`thramixns £3 a Read elm farmed within the blmti
`
`vessel (or heart) cine mauaiiy m a simwing mf the 2:213
`miatim m tea an alteraticm mi the hlvad m vessel
`waii. {Linea “51.35371 2: ciat circulatm it bemmas an my
`
`3mm, carried by the biased stream um} it iadges in
`a b10051 @5395}, abgmmting it? and {making in a
`
`Astraleneca Exhibit 2106 p. 7
`
`

`

`4.0
`
`PQFEfitemis
`
`blockage er ccctueien referred tc: as an cmbclism.
`Such an chetmctien may be a. entice} hazard to the
`patient, depending upon the site anti eevetiw cf the
`ebettuctien.
`
`htttevemuely administered. :1ng crciinerfiy must
`he in equecue selutien; they must mix; with the cir-
`culeting blece and net precipitate from seletien.
`Such an event cetfici lead te puimcnary miqecep-
`iliaty ccctusiee and; the subsequent blockage cf
`tamed passage. Intravencusly delivered fat emul-
`sicne tag”, Iatralipid, 10%;2G% {Cfintec}, Lipc-Syn
`II, 10%;239e {Abbettig Lipceyn III; 10e;20e [Abw
`beet}? have gained acceptance fer use as e emcee e5
`celaries and essetttiel fatty acids fer patients rew
`cutting patenteta} nuttiticn for extendeci periccie cf
`time {ueueliy fer mete than 5 ciaye}. The precinct
`ceramics up te 28% seybeen eil emulsifieti with egg
`yeik phttegzshczaligpitiet in e vehicte cf glycetitt in waw
`ter fer injectieetThe emuieiett is administered via a
`peripheral vein er by central veneue infueicrt.
`Naturally; the intravencus route is used in the
`edminiettetien of bteed trensfueiens and it else
`
`sewee as the paint ct exit in the temwel of bleed
`item patients fer diegtteetic wed: and for cbteirting
`bleed frem itemize.
`
`and are then inesiequete tc treat the pain. The
`FCA can prevent phermecekinetic and phermacw
`fiynemic differences between patients teem inter—
`fering met the effectiveneee of eneigesie. Because
`epieifi kinetics ciiffer greatly mung patients, the
`rates at infitsien must be teticrezi (2}.
`The P655, aiee genetic: patients te medicete them"
`ashes when there is breakthmugh pain; It elimi—
`nates the tieiay between the time at the patients
`eereeptten cf cam and receiving the analgesic medv
`icatiett. Further; it saves nursing time. chemfise,
`the mime mus: check analgesic etciete gieen by the
`physician, ‘3ng cut the pair: teliever ftem a cert»
`tteileé, ieciceti iccatien, and, then administer the
`medicatien te the patient.
`The PCAL else provides better pair: central with
`less side effecte by minimizing the means be“
`tween subcetimel gain relief eat} caveman: of net»
`cetics. When the eitie effect prefiie cf PCA patients
`is compared it) patients meintaincé an FM nap
`cetics, nausea, sedetien; emit teepitatczy depreseiett
`eccer less cftee in the PCet gteup. Lace}: patients
`eccegt the File as a faeerehle made at reliefi pee
`flaps clue m the acme cf being in centtei anti talc»
`
`ing an active pert itt their pain relief.
`
`in the late 1988a; eutemeted intravencue defieety
`systems became cemmercially eeeitebie for inter»
`mtttent; setfvedmjnieerefiett ef enelgeeies. Egg—metre
`centtefieti aneigesia (13%} has beet: used to centre}
`the pate asseciated with peeteperetive pain from a
`variety of Surgical ptecetiuree, label; sickte cell crisis,
`end chtemc pain aseecieteci with cancer! For patients
`with chrcmic malignant pain, Wile aflewe a greater
`degree of ambuietiett end indeeeedence {1).
`The typical PCA device includes 3 Wings: at
`chamber that remains the analgesic drug and
`a ptcgtemmeble electemechenicei emit. The unit,
`which might be cempact eneugjh m be mm cm a
`bett a: carrieti in. a packet (veg, WalkMetim FCA~
`Medea, Inc}, commie the detivery cf drug by ed‘
`matting a piston when the patient presses a batten.
`The drug can be loaded mm the device by a health
`care prefeesieml (3f disPenseci from preloaded car—
`tridges aeailabie thmugh the manufacturer.The tie»
`eicee take advantage of intravencus balms injec»
`time be praduce rapid analgesia; 31921;; with slower
`in feeicm m pmduce steady-mate epiete cancentraw
`fions fer custained pain central.
`The advantage cf the PCA is its 313in to previde
`conetent and uniferm analgesia, The typical intram
`muscular injectien at an cpicié mm a depct
`muscular site may result in tremble absmptim,
`leading to unpredictable 131:1:ch cencenttafimet Fun
`then these injectiens are 1131121in given when needecl
`
`Fig. 1121.2 Pm Pitta II {lfiefiete emeeemmmmygg
`eeefigesic Mesa: (Cflfiffé’sy sf Acme Hespftef Predacts
` fifeésinm}
`
`AstraZeneca Exhibit 2106 pt 8
`
`

`

`Pile tie-vices can be used fer ietraveneue seems
`
`taneeee. er epiduxel edmieietretien. Usually, theee
`devices are either demand eeeteg (Le... e fixed dese
`et' drug is injectetl intermittently} er eeesfemarete
`iefitslee glee Limited easing {2}. Regarelless of type
`utilized, the physician 0! nurse esteblielmee the leeci~
`mg dese. the rate at beekgteuntl infusien, tiese pet
`demenel. leekeet interval (1e. minimum time be»?
`tween demand eases}; and maximum tiesage ever
`a specified time interval. Figute 14.2 demmetretes
`the Fife Plus ll {Lifeeeze ewe) infuser. With thie
`device, the getient pushes a butten en a pendant is;
`deliver a preeetlbed quantity ef the analgesic.
`
`Intramuscular Route
`
`lntremueeulet injectiees ef tituge prettiafle shrug
`etfecte that are lees tepid, but geréerelly of greater:
`duration than these ehteinecl from tettaeeneue ecl-
`
`minietratien {3}. Aqueeue er eleegineus solutiens
`er suspeneiens ef drug substances may be ecimiw
`letereel intremueeulerly. Depending we the type at
`pteparetien empleyetl. the abeerefien rates may
`easy widely. it wattle be expected that (3133.139: in sea»
`lutien wettlti be mete rapidly abserbecl than theee
`in suepeneiee end that druge in equeeue tempera»
`tiene wettltl he were rapidly ebeetbecl than when
`in eleegineue preparetlene. The ehyeieal type 0f
`prepatetien empleyed is beeeztl err. the prepet‘tiee cf
`the chug itself and en the therapeutic geele deeited.
`lntramueculer injeetlens ere perfermetzl (lee? irate
`the skeletal museleefll'te pellet ef ingestien eheulcl be
`as far as peesible {tam majet nerves anti bleed we?
`eels. Injuries. tie patients Efrem ltflmmusculer injectien
`usually axe related te the peim at which the needle
`ettteted and where the medieatien wee depeeited.
`Such ln‘urlee inelude paralysis resulting; {mm [Ritual
`fismege, sheeeseesg cysts, embolism, hemeteme;
`sleughi g at the skin} and see: formatien.
`ln eel
`ltet the upper miter quatltenl till: the gluteus
`mammals 13 the meet frequently need site fer latte“
`museular injection. In infants. the gluteal area is
`email a cl mmpeeed primarily ef fat. net musrde.
`What muscle there is ie pearly clevelepetl. An in-
`jectien 'n this area might be presented dangerously
`elese ts: the sciatic meme. eepeeially if the child is; re»
`existing the injeetmn and equitmirtg er fighting.
`Thus! '1
`infants; areal yeung Cltlltlren, the deltold
`muscles at the upper arm or the mxiletetal muscles
`at” the high are preferred. An injectien given in the
`upper ex: lewer pettion at the delteid wattle be well
`away team the recital memel’he cleéteini may else be
`used in adults; but the pain is mere netéeeatzle here
`than in the gluteel area. ll? 21 SEl‘lES at mteetims are
`to be given. the indecent: site 15 ueuallv varied. Te be
`
`
`
`Peteuremls
`
`le’l
`
`certeie that e bleed vessel has eat been entered,
`the clinician may aspirate slightly on the syringe
`fellewing leeeetien at“ the neenlle te ebsewe if bleed
`enters the syflnge. Usually. the velume 0f medical
`ticm which may he canveejently administered by
`the tntremueeeler mute ie limited; generally a me»
`imam et' 5 ml. is administered intremusculerly in
`the gluteel raglan and 2 mL in the delteitl 0f the
`arm.
`
`The Kvl‘teelc Injectien technique is useful for in»?
`tremueeeler ixtfeetiene ef medieatiene that state
`upper tissue; tag. li’ClI't dextten mjeetiem er these
`that irritate tissue, ega, Valium, by sealing these
`medieetiens in the lewet muscle. Because er”; its
`
`Staining qualities. tree. deetxen injectten. for exam»
`ple, must be injected Ural}; late the muscle mass at
`the upger enter quadrant ef the betteelcszlte skirt is
`displaced latexelly peter te teteetien. then the nee
`tile is inserted end eming'e eeeireted, and the ifljetle
`ticm performed elem}; and smeathlyfllte needle is
`than Mthdrewn and the skirt released. Thie creates
`
`e“3”eattetn that blacks infiltzetien ef meelieetien
`irate the submteneeue tiee:1e.Ӥlte injectien is 2 to 3
`inches deep, and a 2G te 22 gauge neetlle is utilized.
`To further prevent any staining ef upper tissue.
`mentally sane needle is usetl ta: mealtime: the item
`(lemme {rem its empul. and then replaced with an»
`other fer the puzpesee at the tnieetien.
`
`Subcutaneeus Reute
`
`The subcutaneous route may be utilized fer the
`injectmn 13f smell amaunts of medication. The im
`jectien at a drug beneath the surface at the skirt its:
`usuelly made 51": the lease interstitial tissues at the
`enter emfece et’ the upper arm! the antes-rte: eerfeee
`ml the thigh, anti the lewet eettiefi ef the ebdemen.
`The site 0f injectiefi is: usually retefecl when injeea
`time are frequently given. sing, daily ineulin injeew
`liens. Prim“ m injectleng the Skin at the injeetlem
`site ehmld be thoroughly deemed. The maydmum
`ammmt m? medicatien that can be eemllarta'bly ire
`jectecl subcutaneeuely is ebeut 1.3 ml. and garments
`greater than 2 mL will mast likely: came painful
`pressure. Syringes mete up ta 3 mL eepeelties anti
`utilizing neefilee with 24 m 25 gauges are used fer
`subcutaneous injections. These needles will have
`cannula lengths that vary between BIB inch ta '1
`inch. Mast When}: subcutaneeue insulin needlee
`are between 23 to .30 gauge with needle length he
`Ween {#16 m EIS inch. Upem ineettien, if bleed e§~
`peers in the egimgel a new site eheuld be eelected.
`"Drugs that are irritatmg er these that are preeemt
`in thick suspefleim form may pmduee induretien.
`slmaghéng, er ebecese Eermetien and may be pain Eel
`
`Astraleneca Exhibit 2106 p. 9
`
`

`

`41132
`
`Perentemls
`
`re the patient. Such preeeretiene should be mneirlv
`ererl net suitable fer eubeureneeee injeerierr.
`
`Intradermal Renate
`
`germ needle ellewe system access lhmugh the slain
`infer a sellweeallng silicrme plug paelliurred in. the
`water ef the perral,
`
`.fficiel Types eflnjectiens
`
`Aceerciiag re the U313. mleerierre are eegarererfi
`late Eire general rypee all (35 which are suitable far;
`and intensified fer, parenteral erlminietratlen These
`may remain buffers, preservatives, errd ether erlcleri
`eubereneee.
`
`A number {if Substances may be effectively in“
`jeered lrrte the cerium: the mere vascular layer
`ef the eldrt just beneath the epiclerrrrie These
`substances include eerleus agents fer cliegmestic
`rierermirretr‘erre, desenslrlrerien; or immunizatlrm.
`
`The usual sire fer rnlrerlermal injeerien is the ante
`rler surface er the fereerrrr. A Sher: {SIS ire} earl
`narrow gauge (23» t0 26~gaugel needle is usually
`empleyerlr‘l‘he needle is inserted herieerttelly mm
`the skin wirlr the bevel facing ugrrerrlfllre injeerlen
`is mede when the bevel just cliseppeere mm the
`cerium. Usually early sheet 23. 1 rel; velumes may be
`administered in this manner.
`
`Specialized Access
`
`In these instances where it is neeeseery to arl~
`rrrirrleler repeated injectiene ever a perierl 0f time,
`it might be mere prurient re empley devices that
`prerlrle centirrued aeeeee arrel help eliminate rte
`treat pain eseeclered with administrefimrlhtre, it is
`irrrperrerrr its list a few al this junerure.
`Several
`types ef reelral veneer; catheters are
`used in irrelllutlane arrcl an an Qutparlerrl beele. These
`are used fer a variety ef parenteral merlicerlrms leg“
`cancer eherrretherepy; longeerrrr entiblelie therapy,
`rebel parenteral nutrltlerr selullenslr earl their place“
`rrrerrt can remain far a few days re several menths,
`When net in use; these require heperlnieelierr tea
`maintain perency ml the catheter lumen
`The use all plastic,
`indwelling catheters helps
`eliminate the need fer multiple puneneee durirrg ll?
`therapy. Cemeeeed le pulyrérryl ehlrrrirfiefl‘efler‘z, and
`pelyerhylerre, these sheulrl be redlepeqrre re ensure
`that they elemenerrere rdeibllity rm wray films {Jerr—
`ally, rlreee must be removed “ether 218 heme alter inn
`eertlerr'l‘he rheire of catheter depemde upon revere}
`{eaters {egg length ef time el the infeslem perpese
`ml
`the infusion the eonrlillorn’aeailebllll}? of the
`veins}. Three types: rial catheters are available: plain
`plastic; eellreteeerer— needle er earlreter—metelrlr:w
`neerlle‘ and rerlxeterwlrreldemeedle.
`
`implantable rlevlrzer prerede lengnrerrrr rerrmre
`access lrr verifier rlieeeeee. firmer 23ml Hickman
`
`ratherere are nrrrelnle erempleellreee r30 carry a risk
`er marblrlltg including freelure el Elle catheters; errw
`trance sire infection; and Gatherer sepsislhese have
`been derelmperl
`rm eeerceme rarlreter campfire
`rims and are deeignerl to premier: repealed arreee re
`the infusierr elterl‘he delivery catheter can be placed
`lr: a vein; eerily! arreryr rrr CNS system. A Huber
`
`1.
`
`2.
`
`
`
`
`
`" rug] Injecrlenmllquirl preeeretierre that are
`drug euberarreee er eelutlerre rhereef. {Be In»
`sullrr lnjecrleng USP}
`" rug} ferlrrjecrfrmmlfiry solids that; upen the edw
`ditierr er ereralale relrleles, yield eelerlerre can»
`arming in all respects tr} Elle rer;reirerrrer1telferlrrw
`'eerlerre (Ex: Celemerrrlele Smallerrr Ear injeclien}
`3. Drug} lrrjrrrelale Eerrrlereemhiquiri pregaraljens
`ef drug substances. cliesrrlrerl rxr disyereerl irr e
`euiteble emulelerr medium. {Ex Frepelel)
`prew-
`ll. Drug}
`Irrjerrelzle
`Seeperrslerrmlriquirl
`perefime rsl? eelirle suspended in a suitable liq»
`uld medium. (Ex: Methylpredrrleelerre Acetate
`Seepensim)
`5. {Drug} fer lefeclrrlrle Sespensleemllry solids that,
`upen the
`eeldirlerr
`at?
`suitable
`vehicles,
`yield ereperatiene ceralerrrrlrrg in all respeete t0
`the requiremente Ear Infrelelile Srrsperrslarrs. {Ere
`lmiperrem}
`
`The farm in which a giver: drug is prepared fer
`parenteral use by the menufeerurer depends upon
`the nature ef the rlrugg itself; with respect tr; its
`physical and Chemise] chamelerlefics, and alert: upon
`certairr rhereeeutic weelderetlerxe. Generally if a
`drug is unstable in selufier’r, it may be prepared as
`a rlr}: pewder intended fer reenrre‘ri’mrierr with the
`prayer solvent at the lime 0f rte administratiem er
`it may be prepared as e suspenelen flf the clmg par»
`lilClEZ‘S in a vehicle in which the drug is Ensemble. If
`the drug is unstable in the preeenee elf were); that
`selrem may be replaced in inert rrr retally by e eel»
`rent in whichtlre drug is ineeluble. ll rhe rlrugis irr-
`seluble in. water, arr injerricm may be preparerl as arr
`aqueeus suspension er as a eelurirm rrf the drug in
`a suitable noraqueeue seleerrr; such as a regetable
`all if err eqeemrs solemn is desired; a water-sale
`Elle sell ‘5er ml? the lneeluble drug 13 frequently grew
`parerl m sell-35y rhe required selublliqr characterise
`tire. Aqueme er bleedqrrleclble relations may” be
`injerred air-ml); late the bleed stream "Bleerlwlmn
`Humble liqulrle, rag, eleegirxoue mjecrlone and sue»
`
`AstraZeneca Exhibit 2106 p. 10
`
`

`

`premium: cara interrupt the marina} flow of blame?
`admin the circuiamry systara, and their 113a is. gem
`arail}; restricted ta rather than intravamus admirais‘w
`rratiarr. The ansat and duratiarr {if simian {if a ring
`may be aamawhat cantrrrilad by the chemical farm
`{If the drug used, the physical state rs? ma irr§ectim
`(grammar a: auapaaairanl arrd the xrahicla ampiayad.
`Drugs that are very salable in bed}; Bahia ganeraily
`hava the mast rapizi abaarprian anti mast saf artisan
`Thus, drugs in aquamua salutian have 3 meta rapid
`unset ea? aaricn than dc: drugs in aiaagimus 3011:»
`tiara. Drags irr aquaaua aaaparraien are alas mare
`rapid acting than drugs in aiaagimus ausperrsian
`due rat) the: greater miscibility of the arguewua prapaa
`radar“: with the body fluids after injectim and tha
`suhsaquam mare rapid canister fifths drug particiea
`with the bad}? fluids. erentimas more pmimgaci
`drug actiort is daaireri ta reduce the necessity (3f frav
`quantify rapaarad in}er:tianaThaaa lang-arring types
`af injectiana are crammanly rafarreci m as rapasimr‘y
`ar"ri2§ar“‘typaa ca preparatiwa‘
`Tha aaruriana and auspanar‘ans :3}? drugs intansiaci
`far in§acriarr arr: pregarai in fire aama gamma} man -
`net 35 was dismaaed prefirmsly in this text for 50*
`Miriam {Chapter 12} arrri disparae ayatems {Chap
`far 133‘ with the faiirawing differences:
`
`1. Salvants r31" vehiclaa uaari mus: meat spacial pu—
`rify and rather Sta rrdaxds assuring their aafafy‘ by
`injectirm.
`2. The uaa «:15 added substances; as buffers, stabi—
`
`lizers, and antinfirrabia} prasawativeag fail Lifh
`tier specific gradalirras 051136: and are restriatad
`in certain parenteral pruciuctafl‘ha use: of calcar—
`ing agerrta is striatiy grahibitari.
`3. Parenteral praducts are aiways sterilized and
`meat sterility atarrriarris anri must be pymgan-
`fraa.
`
`4, Parm‘rtarai salutimla must meet mmpamiia} stem»
`darda far particulate matter.
`5. Paranterai precincts must be grammar in 321%
`mnmentaily mmmilerfi areas: undar strict army
`terrier: standards, amt by personnel apecially
`trained and claimed to maintain the sanitation
`atanciarria.
`
`{:1 Parenteral products ara yackaged in apeciai her—
`metic containers rrf apatifir and high quality.
`Sperm} quafity rantml prmraduras are utilizes} to
`enaure their hermetic seal and steriirz condirimn.
`
`7, Each remainer flf arr ingecfian is fiiiaxi m a ml~
`nma in sfight «3246933 sf the 1abelred”siae"r3r ml»
`rum: to be Mrhdrawrr. Thia merffll permitg the
`reaae at? withdrawal and administrarim 0f the la—
`belari mirrmea.
`
`Parentamls
`
`4553
`
`8. There are rearriariarra mar rha vealrzrrra af $113639
`rim panaitteci irr muitipla—daae cantair‘aara and
`aim a imitatiarr war the types af containers
`(singiamriasa m muifiplawdasa) which may be
`used far certain injectiana
`9r Spaaific labeling ragularirma apply to injaciianar
`ED. Starfie pawriars intarrdad far salutian var aria»-
`panama :mmadiataiy prim ta irrjecticarr are fra—
`rguarttiy yaakagad a3 fyagahiliaad r3: freazawdriari
`pawdar’s ta permit ease {3f saiaticm a: suspaw
`aim upaa the addirirm surf the salvarrt car vehicia‘
`
`Solvents and Vehicles far Injectians
`
`Thar meat frequanfly used ambient in the larga
`scare manufacmrar 0f injectiana ia Waferfar Irrjactiara
`113?: This watar is purified by distiliarian err by re»
`versa Damasis and meats the aama ataxrdarda far the
`
`presence {3? ratai aafifia aa dmaa Purified Water; LISP,
`am meta than 1 mg per 103 mL Water for Irafiectiam
`US? and may rrat remain added substances. Ab
`margin water far ingaariarr is not required tr) be star—
`fir; it must be pyragamfraeffha water is intendad tr)
`be used in the manufactura 9f injectable pradurta
`whiah are in be stariiiaad after weir prapararicrrr. Wa-
`ter fr): injactian Emma bra atarad if! tight cantainars
`at ramaeramres balaw far abava the rarrge in which
`micmbiai grawth occurs? Water

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket